AGIO
Agios Pharmaceuticals, Inc. ยท Health Care ยท NASDAQ
$35.10
โฒ $0.94 (+2.75%)
52-week range
$22.24 โ $46.00
Agios Pharmaceuticals, Inc. (AGIO) is held by 1 tracked hedge fund(s). Sector: Health Care. Largest tracked holder: ARMISTICE CAPITAL, LLC.
No recent hedge-fund trades on this stock.
Recent hedge fund trades
No recent hedge-fund trades on this stock.
Insider trades open-market, past year
No reported open-market insider trades in the past year.
Open-market Form 4 transactions (grants & option exercises excluded). Live from SEC filings.
Congress buys & sells disclosed trades
No disclosed Congressional trades on this stock.
Price chart
Financials
Symbol info, price chart & financials are live from TradingView (real data โ no processing).
๐
Deep Dive โ full fundamental analysis
An analyst-grade breakdown of AGIO: the bull & bear thesis, valuation model, segment detail and risks โ written from SEC filings.
- Bull & bear case, with conviction score
- Owner-earnings & valuation model
- Segment & geographic revenue breakdown
- Key risks & what would break the thesis
- Peer comparison (vs sector)
๐ Unlock with WealthFile Pro
โก
Daily Moves โ what's moving AGIO today
A daily, plain-English read on the day's price action and the smart-money & news catalysts behind it.
- Today's price drivers, explained
- Smart-money flow alerts (fund / insider / Congress)
- News & SEC-filing catalysts
- Unusual options activity
๐ Unlock with WealthFile Pro
Related โพ
FAQ โพ
Which hedge funds hold AGIO?
Tracked holders include: ARMISTICE CAPITAL, LLC.
How much smart money owns AGIO?
1 tracked hedge fund(s) have disclosed positions.
Are members of Congress trading AGIO?
No tracked Congressional trades in AGIO on file.
Where does this data come from?
SEC 13F filings (funds), Form 4 (insiders) and STOCK Act reports (Congress).
Sourced from SEC 13F, Form 4 & STOCK Act filings ยท Not investment advice โพ
Ownership from SEC filings; price from market data.
Published by WealthFile ยท Not investment advice.